New baby formula with breast milk sugars studied for safety and growth
NCT ID NCT07302477
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new infant formula containing human milk oligosaccharides (HMOs), which are natural sugars found in breast milk, in 125 healthy full-term babies. The goal was to see if the formula supports normal growth and is easy for babies to digest in everyday, real-world conditions. Researchers measured weight, length, head size, and digestive comfort over 8 weeks. The study did not compare the formula to any other feeding method, so it provides early information on how well babies tolerate HMO-supplemented formula outside of a controlled lab setting.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
infant formula supplemented with human milk oligosaccharides (HMOs) and Bifidobacterium lactis
What this could lead to
If successful, this could show that HMO-supplemented formula is a safe and well-tolerated option for healthy infants, potentially supporting normal growth and digestive health.
What could go wrong
This is a small, uncontrolled study without a comparison group, so results may not be conclusive. It only looks at short-term outcomes over 8 weeks, and any benefits seen might not hold up in larger, more rigorous trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVERSE EVENT are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fatima Memorial Hospital
Lahore, Pakistan
-
Khawaja Muhammad Safdar Medical College
Sialkot, Pakistan
-
Liaqat National Hospital
Karachi, Pakistan
-
Quaid E Azam Medical College
Chak Four Hundred Fifty-four, Pakistan